Lars Fischer

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

Eckhard Thiel, Agnieszka Korfel, Peter Martus et al. · The Lancet Oncology · 2010 · 612 citations

Neuro-oncology, Radiation Therapy, Medicine +7

A Systematic Review of Localization, Surgical Treatment Options, and Outcome of Insulinoma

Arianeb Mehrabi, Lars Fischer, Mohammad Hafezi et al. · Pancreas · 2014 · 265 citations

Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

Anthony J. Guidi, Stuart J. Schnitt, Lars Fischer et al. · Cancer · 1997 · 216 citations · Full text

PATIENTS AT RISK FOR DEVELOPMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER: PLASMA VERSUS PERIPHERAL BLOOD MONONUCLEAR CELLS AS MATERIAL FOR QUANTIFICATION OF EPSTEIN-BARR VIRAL LOAD BY USING REAL-TIME QUANTITATIVE POLYMERASE CHAIN REACTION1,2

Hans-Joachim Wagner, Meike Wessel, Wolfram J. Jabs et al. · Transplantation · 2001 · 216 citations

Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors

Kristoph Jahnke, Eckhard Thiel, Peter Martus et al. · Journal of Neuro-Oncology · 2006 · 207 citations

Prognostic Factors, Neuro-oncology, Lymphoid Neoplasia +3